ImmuCell Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 0.00 shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 15.00K shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 4.00K shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2013 was 7.00K shares, a 53.33% decline from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 15.00K shares 10-K · filed 2026-03-30 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 0.00 shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-13 | |
| 2023-12-31 | 4.00K shares 10-K · filed 2024-04-01 | |
| 2013-12-31 | 7.00K shares 10-K · filed 2014-03-26 | |
| 2012-12-31 | 15.00K shares 10-K · filed 2014-03-26 | |
| 2011-12-31 | 31.00K shares 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |